• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TEAD4-DYNLL1轴加速细胞周期进程并增强肺腺癌细胞的恶性特性。

The TEAD4-DYNLL1 axis accelerates cell cycle progression and augments malignant properties of lung adenocarcinoma cells.

作者信息

Li Dapeng, Wang An, Wang Xuan, Shi Mengkun, Chen Xiaofeng, Lyu Yubao, Huang Dayu

机构信息

Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, People's Republic of China.

Department of Thoracic Surgery, Huashan Hospital of Fudan University, Shanghai, 200040, People's Republic of China.

出版信息

Eur J Med Res. 2025 Apr 1;30(1):221. doi: 10.1186/s40001-025-02500-y.

DOI:10.1186/s40001-025-02500-y
PMID:40170083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11959721/
Abstract

BACKGROUND

Lung adenocarcinoma (LUAD) is a major contributor to global mortality. Grounded onto bioinformatics insights, this study probes the functions of dynein light chain LC8-type 1 (DYNLL1) in LUAD progression.

METHODS

DYNLL1 levels in LUAD and normal cells were determined using qPCR and western blotting analyses. Lentiviral plasmids-mediated DYNLL1 silencing was induced in LUAD cells, followed by functional assays to investigate DYNLL1's impacts on proliferation, mobility, apoptosis, and cell cycle distribution. KY19382, a Wnt/β-catenin agonist, was employed to analyze the involvement of the Wnt/β-catenin pathway in DYNLL1's effects. Upstream regulator of DYNLL1 was queried using bioinformatics. Mouse LUAD cells LA795 were implanted into BALB/c nude mice to establish animal tumor models.

RESULTS

DYNLL1 exhibited heightened expression in LUAD cells. Its artificial silencing reduced proliferation and dissemination of cancer cells, promoted cell apoptosis, and induced G0/G1 cell cycle arrest. DYNLL1 silencing reduced β-catenin levels in cancer cells, and KY19382 treatment diminished the effects induced by DYNLL1 silencing. TEA domain transcription factor 4 (TEAD4), upregulated in LUAD cells, binds to the DUNLL1 promoter for transcriptional activation. TEAD4 silencing in LUAD cells reduced DYNLL1 transcription and β-catenin levels, thus suppressing proliferation while promoting apoptosis, senescence, and cell cycle arrest. In vivo, TEAD4 silencing weakened tumorigenesis of LA795 cells. Nevertheless, these phenomena were counteracted by the artificial DYNLL1 restoration in LUAD cells.

CONCLUSION

This investigation demonstrates a TEAD4-DYNLL1 axis that accelerates cell cycle progression and augments malignant properties of LUAD cells via the Wnt/β-catenin pathway.

摘要

背景

肺腺癌(LUAD)是全球死亡率的主要促成因素。基于生物信息学见解,本研究探究动力蛋白轻链LC8型1(DYNLL1)在LUAD进展中的功能。

方法

使用qPCR和蛋白质印迹分析确定LUAD细胞和正常细胞中DYNLL1的水平。在LUAD细胞中诱导慢病毒质粒介导的DYNLL1沉默,随后进行功能测定,以研究DYNLL1对增殖、迁移、凋亡和细胞周期分布的影响。使用Wnt/β-连环蛋白激动剂KY19382分析Wnt/β-连环蛋白途径在DYNLL1作用中的参与情况。使用生物信息学查询DYNLL1的上游调节因子。将小鼠LUAD细胞LA795植入BALB/c裸鼠中以建立动物肿瘤模型。

结果

DYNLL1在LUAD细胞中表达升高。其人工沉默减少了癌细胞的增殖和扩散,促进了细胞凋亡,并诱导了G0/G1细胞周期停滞。DYNLL1沉默降低了癌细胞中β-连环蛋白的水平,KY19382处理减弱了DYNLL1沉默诱导的作用。在LUAD细胞中上调的TEA结构域转录因子4(TEAD4)与DUNLL1启动子结合以进行转录激活。LUAD细胞中的TEAD4沉默降低了DYNLL1转录和β-连环蛋白水平,从而抑制增殖,同时促进凋亡、衰老和细胞周期停滞。在体内,TEAD4沉默减弱了LA795细胞的肿瘤发生。然而,LUAD细胞中的人工DYNLL1恢复抵消了这些现象。

结论

本研究证明了一个TEAD4-DYNLL1轴,该轴通过Wnt/β-连环蛋白途径加速细胞周期进程并增强LUAD细胞的恶性特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/1c3889376893/40001_2025_2500_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/4209cc0fca70/40001_2025_2500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/a2c6af593311/40001_2025_2500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/5032ef3e2edb/40001_2025_2500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/1312192fe6d5/40001_2025_2500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/a6449009b07b/40001_2025_2500_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/83d3af03a9b3/40001_2025_2500_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/1c3889376893/40001_2025_2500_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/4209cc0fca70/40001_2025_2500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/a2c6af593311/40001_2025_2500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/5032ef3e2edb/40001_2025_2500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/1312192fe6d5/40001_2025_2500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/a6449009b07b/40001_2025_2500_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/83d3af03a9b3/40001_2025_2500_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/11959721/1c3889376893/40001_2025_2500_Fig7_HTML.jpg

相似文献

1
The TEAD4-DYNLL1 axis accelerates cell cycle progression and augments malignant properties of lung adenocarcinoma cells.TEAD4-DYNLL1轴加速细胞周期进程并增强肺腺癌细胞的恶性特性。
Eur J Med Res. 2025 Apr 1;30(1):221. doi: 10.1186/s40001-025-02500-y.
2
Long noncoding RNA LINC01106 promotes lung adenocarcinoma progression via upregulation of autophagy.长链非编码RNA LINC01106通过上调自噬促进肺腺癌进展。
Oncol Res. 2024 Dec 20;33(1):171-184. doi: 10.32604/or.2024.047626. eCollection 2025.
3
GINS1 facilitates the development of lung adenocarcinoma via Wnt/β-catenin activation.GINS1通过激活Wnt/β-连环蛋白促进肺腺癌的发展。
World J Surg Oncol. 2025 Apr 7;23(1):122. doi: 10.1186/s12957-025-03786-2.
4
The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.转录因子 TEAD4 通过增强 PKM2 介导的糖酵解促进肺腺癌进展。
Cell Biol Int. 2021 Oct;45(10):2063-2073. doi: 10.1002/cbin.11654. Epub 2021 Jun 30.
5
STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/β-catenin signaling pathway.STAT1 诱导的 LINC00467 上调通过表观遗传沉默 DKK1 来激活 Wnt/β-连环蛋白信号通路,促进肺腺癌细胞的增殖和迁移。
Biochem Biophys Res Commun. 2019 Jun 18;514(1):118-126. doi: 10.1016/j.bbrc.2019.04.107. Epub 2019 Apr 23.
6
IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt/β-Catenin signaling pathway.IL-17A 诱导的癌症相关成纤维细胞通过 Wnt/β-连环蛋白信号通路释放 CXCL12 促进肺腺癌的进展。
Cytokine. 2024 Aug;180:156676. doi: 10.1016/j.cyto.2024.156676. Epub 2024 Jun 9.
7
Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.连接黏附分子样蛋白通过 Wnt/β-连环蛋白信号通路促进肺腺癌的肿瘤进展。
J Transl Med. 2022 Jun 7;20(1):260. doi: 10.1186/s12967-022-03457-w.
8
TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression.TEAD4 发挥促转移作用,并在肺腺癌进展中受 miR6839-3p 的负调控。
J Cell Mol Med. 2018 Jul;22(7):3560-3571. doi: 10.1111/jcmm.13634. Epub 2018 Apr 18.
9
HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.HIF-1α 调控的 miR-1275 通过同时激活 Wnt/β-catenin 和 Notch 信号通路来维持肺癌干细胞样表型并促进 LUAD 的进展。
Theranostics. 2020 Jan 22;10(6):2553-2570. doi: 10.7150/thno.41120. eCollection 2020.
10
Transcription Factor FOSL1 Promotes Cisplatin Resistance in Non-Small Cell Lung Cancer Cells by Modulating the Wnt3a/β-Catenin Signaling through Upregulation of PLIN3 Expression.转录因子FOSL1通过上调PLIN3的表达调节Wnt3a/β-连环蛋白信号通路,从而促进非小细胞肺癌细胞对顺铂的耐药性。
Front Biosci (Landmark Ed). 2025 Mar 19;30(3):26898. doi: 10.31083/FBL26898.

本文引用的文献

1
Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer.基线肿瘤血管灌注作为非小细胞肺癌免疫检查点治疗的一种非侵入性预测生物标志物。
BMJ Oncol. 2024 Aug 21;3(1):e000473. doi: 10.1136/bmjonc-2024-000473. eCollection 2024.
2
Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma.TACC3在泛癌中的预后及免疫治疗作用及其对肺腺癌增殖和多西他赛耐药性的影响
Oncology. 2025;103(7):628-643. doi: 10.1159/000542450. Epub 2024 Nov 7.
3
Matrix stiffness-related extracellular matrix signatures and the DYNLL1 protein promote hepatocellular carcinoma progression through the Wnt/β-catenin pathway.
基质硬度相关的细胞外基质特征和 DYNLL1 蛋白通过 Wnt/β-catenin 通路促进肝癌进展。
BMC Cancer. 2024 Sep 30;24(1):1211. doi: 10.1186/s12885-024-12973-5.
4
The Interaction of Calcium-Sensing Receptor with KIF11 Enhances Cisplatin Resistance in Lung Adenocarcinoma via BRCA1/cyclin B1 pathway.钙敏感受体与驱动蛋白家族成员11的相互作用通过BRCA1/细胞周期蛋白B1途径增强肺腺癌对顺铂的耐药性。
Int J Biol Sci. 2024 Jul 15;20(10):3892-3910. doi: 10.7150/ijbs.92046. eCollection 2024.
5
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity.DYNLL1 通过 ILF2/CDK4 轴加速细胞周期进程,促进肝细胞癌的发展和帕博西尼敏感性。
Br J Cancer. 2024 Jul;131(2):243-257. doi: 10.1038/s41416-024-02719-2. Epub 2024 Jun 1.
6
DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.DLGAP5 通过上调 PLK1 促进肺腺癌生长,可作为治疗靶点。
J Transl Med. 2024 Feb 27;22(1):209. doi: 10.1186/s12967-024-04910-8.
7
lncRNA CERS6-AS1 upregulates the expression of ANLN by sponging miR-424-5p to promote the progression and drug resistance of lung adenocarcinoma.长链非编码RNA CERS6-AS1通过海绵吸附miR-424-5p上调ANLN的表达,从而促进肺腺癌的进展和耐药性。
Noncoding RNA Res. 2023 Dec 1;9(1):221-235. doi: 10.1016/j.ncrna.2023.11.013. eCollection 2024 Mar.
8
Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.非小细胞肺癌的预后因素和标志物:最新进展和未来挑战。
Genes (Basel). 2023 Oct 4;14(10):1906. doi: 10.3390/genes14101906.
9
The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective.免疫治疗非小细胞肺癌的预后生物标志物:现状与展望。
Front Immunol. 2023 Sep 11;14:1249980. doi: 10.3389/fimmu.2023.1249980. eCollection 2023.
10
YAP/TEAD-induced PRIM1 contributes to the progression and poor prognosis of gastric carcinoma.YAP/TEAD诱导的PRIM1促进胃癌进展并导致不良预后。
Transl Oncol. 2023 Dec;38:101791. doi: 10.1016/j.tranon.2023.101791. Epub 2023 Sep 21.